Please assess the completion status of the following clinical trial:

Trial Title: Tailored Therapy for Helicobacter Pylori Rescue Treatment

Study Design Characteristics:
- Allocation: None
- Intervention Model: SINGLE_GROUP
- Observational Model: None
- Primary Purpose: TREATMENT
- Time Perspective: None
- Masking: NONE
- Phase: PHASE4
- Number of Arms: 1.0

Eligibility Criteria:
Inclusion Criteria:~* Participants with non-ulcer functional dyspepsia or scarred peptic ulcer disease~* Previous failures of H. pylori eradication therapy and need rescue therapy~* Ability and willingness to participate in the study and to sign and give informed consent~* Confirmed H. pylori infection~Exclusion Criteria:~* Less than 18 years old~* With previous gastric surgery~* Major systemic diseases~* Pregnancy or lactation~* Allergy to any of the study drugs~* Administration of antibiotics, bismuth, antisecretory drugs in 8 weeks prior to inclusion

- Gender: ALL
- Minimum Age: 18 Years
- Maximum Age: 75 Years
- Healthy Volunteers: f

Study Arms:
- Tailored Therapy (Type: EXPERIMENTAL): After antimicrobial susceptibility testing of Helicobacter pylori from biopsy samples, according to antibiotic resistance pattern of each one, give esomeprazole, amoxicillin and one sensitive of clarithromycin, metronidazole and levofloxacin.If isolates were resistant to all three tested antibiotics, give esomeprazole, bismuth potassium citrate, metronidazole and amoxicillin for 14 days.

Based on this trial design, predict the completion outcome and termination type (if applicable).